Carrick Therapeutics, a Dublin-headquartered biopharma firm, has landed a $35 million investment from Pfizer as it also confirmed the final closure of a $25 million Series C funding round.
The company which is developing pioneering treatments to defeat some of the most aggressive cancers was founded by Elaine Sullivan, a former vice-president for research and development at both Eli Lilly and AstraZeneca, in 2016.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر: